Aurobindo Pharma’s profit rises on steady domestic demand
(Reuters) -Indian drugmaker Aurobindo Pharma reported a 3.8% rise in profit on Wednesday, helped by steady domestic demand, especially for its anti-retroviral drugs for HIV infections. Consolidated net profit in the second quarter rose to 8.48 billion rupees ($96.48 million) from 8.17 billion rupees a year ago. Revenue rose 8.37% to 82.86 billion rupees. For …
Aurobindo Pharma’s profit rises on steady domestic demand Read More »





